John Alexander

4.4k citations

72 papers · 2.6k indexed · 1 hit paper · h-index 26

Impact in

Ophthalmology top 2%
- Retinal Diseases and Treatments
Genetics top 5%
- Virus-based gene therapy research

Papers in ⓘ

Ophthalmology 8
- Retinal Diseases and Treatments 6
Genetics 15
- Virus-based gene therapy research 6

Co-authors: Harry B. Gray (1 shared paper)William W. Hauswirth (15 shared papers)Monika Bullinger (1 shared paper)Andreas M. Pleil (1 shared paper)Luís Rajmil (1 shared paper)Anne W. Riley (1 shared paper)Donald L. Patrick (1 shared paper)Louis S. Matza (1 shared paper)
Journals: Journal of Organometallic Chemistry (4 papers)Investigative Ophthalmology & Visual Science (4 papers)Inorganica Chimica Acta (3 papers)Nature Communications (2 papers)Cancer Research (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

John Alexander

68 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force 2013 · 343 citations

Peers

Countries citing papers authored by John Alexander

Since Specialization

Citations

This map shows the geographic impact of John Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Alexander more than expected).

Fields of papers citing papers by John Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Alexander. The network helps show where John Alexander may publish in the future.

Co-authors

The 25 scholars most cited alongside John Alexander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Alexander Line = papers co-authored together John Alexander links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force Value in Health ·Louis S. Matza, Donald L. Patrick, Anne W. Riley, John Alexander, Luís Rajmil, Andreas M. Pleil, Monika Bullinger Hit paper breakdown →	2013	343
2	Electronic structures of hexacyanometalate complexes Journal of the American Chemical Society ·John Alexander, Harry B. Gray	1968	262
3	Gene therapy rescues cone function in congenital achromatopsia Human Molecular Genetics ·András M. Komáromy, John Alexander, Jessica S. Rowlan, Monique M. Garcia, Vince A. Chiodo, Asli Kaya, Jacqueline C. Tanaka, Gregory M. Acland, William W. Hauswirth, Gustavo D. Aguirre	2010	204
4	DicerInactivation Leads to Progressive Functional and Structural Degeneration of the Mouse Retina Journal of Neuroscience ·Devid Damiani, John Alexander, Jason ORourke, Michael T. McManus, Ashutosh P. Jadhav, Constance L. Cepko, William W. Hauswirth, Brian D. Harfe, Enrica Strettoi	2008	180
5	Restoration of cone vision in a mouse model of achromatopsia Nature Medicine ·John Alexander, Yumiko Umino, Drew Everhart, Bo Chang, Seok Hong Min, Qiuhong Li, Adrian M. Timmers, Norman L. Hawes, Jijing Pang, Robert B. Barlow, William W. Hauswirth	2007	174
6	Clinical BRCA1/2 Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy Resistance Cancer Discovery ·Stephen J. Pettitt, Jessica Frankum, Marco Punta, Stefano Lise, John Alexander, Yi Chen, Timothy A. Yap, Syed Haider, Andrew Tutt, Christopher J. Lord	2020	114
7	The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate Retina Human Gene Therapy ·Sanford L. Boye, John Alexander, C. Douglas Witherspoon, Kristen J. Sandefer, Thomas J. Conlon, Kirsten Erger, Jingfen Sun, Renee C. Ryals, Vince A. Chiodo, Mark E. Clark, Christopher A. Girkin, William W. Hauswirth, Paul D. Gamlin	2012	89
8	Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions Nature Communications ·Oliver Thompson, Ferdinand von Meyenn, Zoë Hewitt, John Alexander, Andrew Wood, Richard Weightman, Siân Gregory, Felix Krueger, Simon Andrews, Ivana Barbaric, Paul J. Gokhale, H. D. M. Moore, Wolf Reik, Marta Milo, Serena Nik‐Zainal, Kosuke Yusa, Peter W. Andrews	2020	82
9	Vitamin D Levels in Subjects With and Without Type 1 Diabetes Residing in a Solar Rich Environment Diabetes Care ·Lindsey Bierschenk, John Alexander, Clive Wasserfall, Michael J. Haller, Desmond Schatz, Mark A. Atkinson	2009	71
10	Modelling mutational landscapes of human cancers in vitro Scientific Reports ·Magali Olivier, Annette Weninger, Maude Ardin, Hana Hušková, Xavier Castells, Maxime Vallée, James McKay, Tatiana Nedelko, Karl–Rudolf Muehlbauer, Hiroyuki Marusawa, John Alexander, Lee Hazelwood, Graham Byrnes, Monica Hollstein, Jiří Zavadil	2014	68
11	Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel Pediatric Neurology ·Kameryn M. Butler, Cristina da Silva, John Alexander, Madhuri Hegde, Andrew Escayg	2017	67
12	Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina Human Gene Therapy ·Sanford L. Boye, John Alexander, C. Douglas Witherspoon, Jim Peterson, Mark E. Clark, Kristen J. Sandefer, Christopher A. Girkin, William W. Hauswirth, Paul D. Gamlin	2016	65
13	Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency Gene Therapy ·Jijing Pang, Sanford L. Boye, Bo Lei, Drew Everhart, Renee C. Ryals, Yumiko Umino, Bärbel Rohrer, John Alexander, Jie Li, Xufeng Dai, Qiuhong Li, Bo Chang, Robert B. Barlow, William W. Hauswirth	2010	63
14	Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations Molecular Therapy ·William A. Beltran, Artur V. Cideciyan, Sanford L. Boye, Guojie Ye, Simone Iwabe, Valérie Dufour, Luis Felipe Marinho, Małgorzata Świder, Mychajlo S. Kosyk, Jin Sha, Jim Peterson, C. Douglas Witherspoon, John Alexander, Gui‐Shuang Ying, Mark S. Shearman, Jeffrey D. Chulay, William W. Hauswirth, Paul D. Gamlin, Samuel G. Jacobson, Gustavo D. Aguirre	2017	62
15	Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice Diabetes ·Matthew Parker, Song Xue, John Alexander, Clive Wasserfall, Martha Campbell‐Thompson, Manuela Battaglia, Silvia Gregori, Clayton E. Mathews, Sihong Song, Misty Troutt, Scott Eisenbeis, John M. Williams, Desmond Schatz, Michael J. Haller, Mark A. Atkinson	2009	60
16	Choice and Doses of Antibacterial Agents for Cement Spacers in Treatment of Prosthetic Joint Infections: Review of Published Studies Clinical Infectious Diseases ·Dmitri Iarikov, Hany W. Demian, Daniel B. Rubin, John Alexander, Sumathi Nambiar	2012	58
17	Targeting gene expression to cones with human cone opsin promoters in recombinant AAV Gene Therapy ·András M. Komáromy, John Alexander, Ann Cooper, Vince A. Chiodo, Gregory M. Acland, William W. Hauswirth, Geoffrey K. Aguirre	2008	48
18	Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease Genetics in Medicine ·Silvia Tortorelli, Jason S. Eckerman, Joseph J. Orsini, Colleen F. Stevens, Jeremy Hart, Patricia Hall, John Alexander, Dimitar Gavrilov, Devin Oglesbee, Kimiyo Raymond, Dietrich Matern, Piero Rinaldo	2017	44
19	Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis Nature Communications ·Ute Jungwirth, Antoinette van Weverwijk, Rachel J. Evans, Liam Jenkins, David Vicente, John Alexander, Qiong Gao, Syed Haider, Marjan Iravani, Clare M. Isacke	2021	43
20	Achromatopsia as a Potential Candidate for Gene Therapy Advances in experimental medicine and biology ·Jijing Pang, John Alexander, Bo Lei, Wen‐Tao Deng, Keqing Zhang, Qiuhong Li, Bo Chang, William W. Hauswirth	2009	38

About John Alexander

John Alexander is a scholar working on Ophthalmology, Genetics, Molecular Biology, Inorganic Chemistry and Oncology, having authored 72 papers that have together received 2.6k indexed citations. Recurring topics across this work include Retinal Development and Disorders (16 papers), Retinal Diseases and Treatments (6 papers), Virus-based gene therapy research (6 papers), Boron Compounds in Chemistry (5 papers), CRISPR and Genetic Engineering (4 papers), Radioactive element chemistry and processing (4 papers), Neuroscience and Neural Engineering (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Ophthalmology (341 citations), Genetics (639 citations), Molecular Biology (1.3k citations), Cancer Research (227 citations) and Cellular and Molecular Neuroscience (261 citations). John Alexander has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Harry B. Gray, William W. Hauswirth, Monika Bullinger, Andreas M. Pleil, Luís Rajmil, Anne W. Riley, Donald L. Patrick, Louis S. Matza, Vince A. Chiodo and Sanford L. Boye. Their work appears in journals such as Journal of Organometallic Chemistry, Investigative Ophthalmology & Visual Science, Inorganica Chimica Acta, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact